secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aspira Women's Health Inc. (AWHL)
CIK:        0000926617
Form:       8-K/A
Filed at:   2026-07-07T20:32:48+00:00
Accession:  0000926617-26-000050
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aspira Women's Health finalizes CEO Buhle separation: $200K severance, 64,583 options accelerated
--------------------------------------------------------------------------------

- Cash severance $200,000 (6 months base salary) payable in installments; prorated $4,615.38 on July 15 payroll if signed by June 29.
- Accelerated vesting of 64,583 stock options at $0.07/share, subject to Compensation Committee approval; all other unvested options forfeited.
- Shares from accelerated options subject to restrictions: 90-day lock-up, daily volume limit 2,500 shares, price floor $0.45, approved broker, advance notice.
- COBRA premium payments for 6 months; mutual release of claims; Buhle remains bound by confidentiality, non-solicitation, non-interference covenants.
- Separation Agreement effective after 7-day revocation period (expected July 6, 2026).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/926617/000092661726000050/0000926617-26-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/926617/000092661726000050/awhl-20260617x8ka.htm
  HTML page:      https://secwatch.observer/filing/0000926617-26-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer